Keywords: Genzyme, FDA approval, Lumizyme, Pompe disease, Myozyme

Good news at last for Genzyme, which gets FDA approval for Lumizyme earlier than anticipated

Article | 26 May 2010

Print This

Troubled US biotechnology firm Genzyme has at last received some good news, with the Food and Drug Administration granting marketing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in